PubMed Health⌕ Search

PubMed · 11712033

When should sunscreen be reapplied?

Abstract

BACKGROUND: A common recommendation by many public health agencies is to reapply sunscreen every 2 to 3 hours. Is this recommendation effective in minimizing ultraviolet exposure of the skin during time in the sun? OBJECTIVE: The purpose of this article is to determine how the time of sunscreen reapplication affects the solar ultraviolet exposure of the skin. METHODS: A mathematical model was derived that took into account typical amounts of sunscreen application and sunscreen substantivity to determine how these factors, when combined with the time of sunscreen reapplication, influence the photoprotection provided by sunscreen during exposure for several hours around mid day in strong sunshine. RESULTS: Using a sunscreen that is readily removed from the skin achieves little in the way of sun protection, no matter when it is reapplied. For sunscreens that bind moderately or well to skin, typical of modern waterproof or water-resistant products, the lowest skin exposure results from early reapplication into the sun exposure period, and not at 2 to 3 hours, after initial application. Typically reapplication of sunscreen at 20 minutes results in 60% to 85% of the ultraviolet exposure that would be received if sunscreen were reapplied at 2 hours. CONCLUSIONS: Advice given to sunscreen users should be to apply sunscreen liberally to exposed sites 15 to 30 minutes before going out into the sun, followed by reapplication of sunscreen to exposed sites 15 to 30 minutes after sun exposure begins. Further reapplication is necessary after vigorous activity that could remove sunscreen, such as swimming, toweling, or excessive sweating and rubbing.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B L Diffey. 2001. When should sunscreen be reapplied?. https://doi.org/10.1067/mjd.2001.117385

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗